Terazosin Hydrochloride
Product Images NDC 53808-0923

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Terazosin Hydrochloride (NDC 53808-0923). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by State Of Florida Doh Central Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Terazosin HCl 1 mg Caps (Terazosin 1mg(teva))

Packaging label for Terazosin Hydrochloride 1 mg capsules, quantity 30, labeled RX Only. The label indicates packaging by DOH Central Pharmacy in Tallahassee, FL, and includes lot number K0920 and expiration date 08/31/10. It displays a barcode and UPC# 300934336054.*

FDA Label Image

Terazosin HCl 2 mg Caps (Terazosin 2mg(teva))

Package label for Terazosin Hydrochloride 2 mg capsules, prescription only, quantity of 30. Labeled by the State of Florida DOH Central Pharmacy in Tallahassee, FL. Includes lot number K1051, expiration date 03/2010, and barcode with UPC 33394337013.*

FDA Label Image

Chemical Structure (Terazosin Hydrochloride Capsules 1)

Chemical structure of Terazosin Hydrochloride showing its molecular formula C19H25N5O4 with hydrochloride (HCl). The structure includes fused rings and various functional groups consistent with Terazosin's chemical composition.*

FDA Label Image

Figure 1 (Terazosin Hydrochloride Capsules 2)

A scientific figure titled 'Figure 1, Study 1' displaying two line graphs. The left graph shows the mean change in total symptom score from baseline over three months comparing placebo and terazosin groups. The right graph shows the mean increase in peak flow rate (mL/sec) from baseline over the same period for the two groups, with statistical significance indicated for placebo at month 1.*

FDA Label Image

Figure 2 (Terazosin Hydrochloride Capsules 3)

A line graph titled 'Mean Change in Total Symptom Score from Baseline' showing data from a long-term, open-label, non-placebo controlled study with 494 participants. The x-axis represents time in months (0 to 30), and the y-axis shows mean change from baseline values. Two lines depict change over time with several points marked as statistically significant compared to baseline.*

FDA Label Image

Figure 3 (Terazosin Hydrochloride Capsules 4)

A line graph titled 'Mean Change in Peak Flow Rate from Baseline Long-Term, Open-Label, Non-Placebo Controlled Study (N=494).' The y-axis shows mean change from baseline in liters per second, ranging from 0 to 4.5, and the x-axis shows time in months from 0 to 30. Data points illustrate an increasing trend in peak flow rate over the study period, with statistically significant changes marked by asterisks.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.